- Q3 2026 total revenue reached $68M compared to $70M in Q3 2025.
- Full-year 2026 adjusted total revenue guidance raised by $145M to $385M–$415M (midpoint $400M).
- Achieved $125M milestone payment from Sanofi following Phase 3 trial initiation.
Signal #144879 · SEC 8-K
$NVAX SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $NVAX filing catalyst
Why did $NVAX trigger an AI stock catalyst alert?
$NVAX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Novavax Raises FY 2026 Adjusted Revenue Guidance to $385M-$415M on $125M Sanofi Milestone. Key points: - Q3 2026 total revenue reached $68M compared to $70M in Q3 2025. - Full-year 2026 adjusted total revenue guidance raised by $145M to $385M–$415M (midpoint $400M). - Achieved $125M milestone payment from Sanofi following Phase 3 trial initiation.
How did $NVAX stock react after the SEC filing?
After the SEC 8-K for $NVAX, observed market reaction: T0 price $10.65. Past moves do not guarantee future results.
Where can I get real-time $NVAX SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $NVAX via Telegram and the VIP Web Terminal from €10/month.